Graduate School of Science and Engineering, Yamagata University, 4-3-16 Jonan, Yonezawa, Yamagata 992-8510, Japan; International Center for Materials Nanoarchitectonics (MANA), National Institute for Materials Science, 1-1 Namiki, Tsukuba, Ibaraki 305-0044, Japan.
Biochem Biophys Res Commun. 2013 Sep 20;439(2):291-6. doi: 10.1016/j.bbrc.2013.08.038. Epub 2013 Aug 23.
Extracellular matrix (ECM) has been focused to understand tumor progression in addition to the genetic mutation of cancer cells. Here, we prepared "staged tumorigenesis-mimicking matrices" which mimic in vivo ECM in tumor tissue at each malignant stage to understand the roles of ECM in tumor progression. Breast tumor cells, MDA-MB-231 (invasive), MCF-7 (non-invasive), and MCF-10A (benign) cells, were cultured to form their own ECM beneath the cells and formed ECM was prepared as staged tumorigenesis-mimicking matrices by decellularization treatment. Cells showed weak attachment on the matrices derived from MDA-MB-231 cancer cells. The proliferations of MDA-MB-231 and MCF-7 was promoted on the matrices derived from MDA-MB-231 cancer cells whereas MCF-10A cell proliferation was not promoted. MCF-10A cell proliferation was promoted on the matrices derived from MCF-10A cells. Chemoresistance of MDA-MB-231 cells against 5-fluorouracil increased on only matrices derived from MDA-MB-231 cells. Our results showed that the cells showed different behaviors on staged tumorigenesis-mimicking matrices according to the malignancy of cell sources for ECM preparation. Therefore, staged tumorigenesis-mimicking matrices might be a useful in vitro ECM models to investigate the roles of ECM in tumor progression.
细胞外基质 (ECM) 除了癌症细胞的基因突变外,还被关注用于了解肿瘤的进展。在这里,我们制备了“模拟肿瘤发生的阶段性基质”,以模拟肿瘤组织中每个恶性阶段的体内 ECM,以了解 ECM 在肿瘤进展中的作用。将乳腺癌细胞 MDA-MB-231(侵袭性)、MCF-7(非侵袭性)和 MCF-10A(良性)培养在细胞下方形成自身 ECM,并通过去细胞化处理将形成的 ECM 制备成模拟肿瘤发生的阶段性基质。细胞在源自 MDA-MB-231 癌细胞的基质上的附着较弱。MDA-MB-231 和 MCF-7 的增殖在源自 MDA-MB-231 癌细胞的基质上得到促进,而 MCF-10A 细胞的增殖则没有得到促进。MCF-10A 细胞在源自 MCF-10A 细胞的基质上的增殖得到促进。MDA-MB-231 细胞对 5-氟尿嘧啶的化疗耐药性仅在源自 MDA-MB-231 细胞的基质上增加。我们的结果表明,细胞在根据 ECM 制备来源细胞的恶性程度的模拟肿瘤发生的阶段性基质上表现出不同的行为。因此,模拟肿瘤发生的阶段性基质可能是一种有用的体外 ECM 模型,可用于研究 ECM 在肿瘤进展中的作用。